首页> 外文期刊>Biomaterials >An osteogenic cell culture system to evaluate the cytocompatibility of Osteoset (R), a calcium sulfate bone void filler
【24h】

An osteogenic cell culture system to evaluate the cytocompatibility of Osteoset (R), a calcium sulfate bone void filler

机译:一种成骨细胞培养系统,用于评估Osteoset(R)(一种硫酸钙骨空隙填充剂)的细胞相容性

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The purpose of the study was to describe a convenient, reliable and quantitative in vitro assay system to assess the cytocompatibility of a calcium sulfate bone filler on two osteogenic cell lines and primary osteoblasts. The hypothesis was that the bone void tiller, OsteoSet(R) pellets, would not impact adversely on cell proliferation kinetics or osteogenic potential of selected cells. The hypothesis was tested by standard in vitro methodology of placing OsteoSet(R) pellets either directly in contact with osteogenic cells, or by compartmentalizing within transwell(R) - clear microporous membrane inserts. Data analyses were accomplished with appropriate post hoc statistics (p less than or equal to 0.05). In the presence of the OsteoSet(R) pellets, the cell lines exhibited a decrease in cell proliferation at days 4 and 7, independent of either cell type or tissue culture medium. A decrease in the alkaline phosphatase enzyme activity occurred in the osteogenic cell lines maintained for 9 and 16 days in the presence of the OsteoSet(R) pellets. However, with the exception of the MC3T3E-1 line, no differences were observed with respect to calcium deposition (mineralization)by day 16. Intact human osteocalcin release data for the human-derived OPC1 line and the primary osteoblasts was inconclusive as the OsteoSet(R) pellets may interact with the osteocalcin secreted into the tissue culture medium. The present studies describe a cell culture system to assess the cytocompatibility of bone-graft substitutes with osteogenic cells by compartmentalizing material from direct cell contact tin transwells(R), and additionally, by evaluating direct cell/biomaterial interactions. (C) 2000 Elsevier Science Ltd. All rights reserved. [References: 35]
机译:该研究的目的是描述一种方便,可靠和定量的体外测定系统,以评估硫酸钙骨填充剂在两种成骨细胞系和原代成骨细胞上的细胞相容性。假设是骨空隙分Ost OsteoSet颗粒不会对所选细胞的细胞增殖动力学或成骨潜能产生不利影响。该假说通过标准的体外方法进行了测试,该方法将小丸直接与成骨细胞接触,或在透明的微孔膜插入物内隔室放置。数据分析是通过适当的事后统计完成的(p小于或等于0.05)。在存在沉淀的情况下,细胞系在第4天和第7天表现出细胞增殖的减少,而与细胞类型或组织培养基无关。在存在OsteoSet沉淀的情况下维持9天和16天的成骨细胞系中碱性磷酸酶活性降低。但是,除MC3T3E-1品系外,到第16天钙沉积(矿化)方面均未观察到差异。人源OPC1品系的完整人骨钙素释放数据和原代成骨细胞尚无定论,如OsteoSet( R)沉淀可能与分泌到组织培养基中的骨钙素相互作用。本研究描述了一种细胞培养系统,其通过分隔来自直接细胞接触的细胞和通过评估直接细胞/生物材料的相互作用来评估骨移植替代物与成骨细胞的细胞相容性。 (C)2000 Elsevier ScienceLtd。保留所有权利。 [参考:35]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号